About the program
The program works with innovative companies developing technology that enables or improves processes and productivity using:
- AI-powered natural language processing
- Computer vision
- Machine learning
- Predictive analysis
About the program

Program objectives
- Enable U.K. ventures the opportunity to explore the potential of overseas markets, like Canada, before they grow while providing valuable insights into the local ecosystem and its business potential.
- Assisting ventures in evaluating tech-market fit, validating initial customer interest, and building connections within Canada’s ecosystem.
- Enhancing economic bonds between Canada and the U.K., fostering collaborative growth.
Program objectives

Chen Mao Davies, LatchAid (Anya)
Founder and CEO

Anya has developed an app to help women navigate issues around their reproductive health as well as manage their overall well-being at various stages of life. Based in Gloucestershire, U.K., the company allows users to interact with both chatbots and human healthcare providers. This app offers 24/7 virtual consultation and private specialist care, personal health tracking, breastfeeding tutorials, personalized content and access to an online community of fellow users.
Damian O'Boyle, Healthy IO
General Manager

Healthy.io is turning smartphones into at-home medical devices. With offices in London, U.K., Boston and Tel Aviv, the company ships do-it-yourself urine tests to patients’ homes. Users can scan a QR code to relay results directly to physicians, speeding up diagnosis and treatment for everything from routine checkups and UTI tests to more serious issues, such as kidney disease. The company can also deploy smartphone cameras to perform wound assessment for people of all skin tones and under any type of lighting.
David Newton, Akrivia Health
Founder and Chief Business Officer

Spun out of research conducted at the University of Oxford and the NHS, Akrivia Health harnesses data to help improve treatment of mental health disorders, including bipolar disorder, schizophrenia, depression and dementia. The company’s platform enables healthcare organizations, researchers and drug developers to work with its in-depth data set, which contains more than 17 billion data points of anonymized patient-clinician interactions, and unlock insights on disease outcome and the efficacy of medicines and treatments.
Harvinder Power, Motics
Co-founder and CEO

London, U.K.-based Motics’s smart platform helps doctors to focus on patients, rather than paperwork. Its program allows healthcare professionals to automate clinical notes, manage insurance claims, reimbursements and clinic billing, as well as answer patient calls and book appointments.
Ioannis Gkouzionis, Aisthesis Medical
Co-founder and CEO

Based in London, U.K., Aisthesis Medical, has developed a wearable medical device that alerts healthcare providers of a patient’s sepsis risk up to 48 hours before symptoms appear. Using AI and machine learning, the device monitors and analyzes various clinical data points, such as vital signs, medical history, medication and lab results, providing doctors and nurses with a sepsis risk score.
James Lomas, Blüm Health
Co-founder and CTO

Based in Liverpool and London, U.K., Blüm Health helps healthcare organizations make the transition to digital patient care. From the design and development stages to customer support, Blüm helps healthcare providers switch to electronic patient records, implement cloud services and AI automation with the goal of providing better care for patients.
Michael Watts, Blüm Health
Co-founder and Managing Director

Based in Liverpool and London, U.K., Blüm Health helps healthcare organizations make the transition to digital patient care. From the design and development stages to customer support, Blüm helps healthcare providers switch to electronic patient records, implement cloud services and AI automation with the goal of providing better care for patients.
Nicolas Shiaelis, Pictura Bio
Founder

Established in 2022 as a spin-out from the University of Oxford, Pictura Bio has developed a device that uses digital technology to analyze medical specimens for pathogens on the spot rather than sending them to a lab. By using optical engineering and machine learning, the company’s test can provide results in less than a minute.
Shaobin Wu, C-PRIO
Principal Cofounder

C-Prio, based out of Chelmsford, U.K., has developed an AI-powered tool aimed at improving colorectal cancer patient outcomes. This solution analyzes tissue biopsies with the goal of speeding up diagnoses, easing lab workloads and reducing patient backlogs.